SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-19-000526
Filing Date
2019-05-15
Accepted
2019-05-15 07:51:24
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT htbx_10q.htm 10-Q 487082
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex31z1.htm EX-31.1 11816
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex31z2.htm EX-31.2 11867
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex32z1.htm EX-32.1 4797
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex32z2.htm EX-32.2 4782
  Complete submission text file 0001553350-19-000526.txt   3344341

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE htbx-20190331.xml EX-101.INS 534482
7 XBRL SCHEMA FILE htbx-20190331.xsd EX-101.SCH 42094
8 XBRL CALCULATION FILE htbx-20190331_cal.xml EX-101.CAL 73813
9 XBRL DEFINITION FILE htbx-20190331_def.xml EX-101.DEF 127229
10 XBRL LABEL FILE htbx-20190331_lab.xml EX-101.LAB 338875
11 XBRL PRESENTATION FILE htbx-20190331_pre.xml EX-101.PRE 256251
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 19825118
SIC: 2834 Pharmaceutical Preparations